Biotricity, Inc. - Condensed Consolidated Balance Sheets - USD ($)		Mar. 31, 2016	Dec. 31, 2015
Current Assets:
Cash		$ 53,643	$ 410,601
Harmonized sales tax recoverable		28,656	36,291
Deposits and other receivables		77,186	72,202
Total Assets		159,485	$ 519,094
Current Liabilities:
Due to shareholders	[1]	53,606
Convertible promissory notes	[2]	102,744
Derivative liabilities	[3]	75,111
Accounts payable and accrued liabilities	[4]	463,328	$ 413,273
Total current liabilities		694,789	413,273
Convertible promissory note	[2]	854,751	783,778
Derivative liabilities	[3]	1,179,923	561,220
TOTAL LIABILITIES		2,729,463	1,758,271
Stockholders' Deficiency:
Preferred stock	[5]	1	1
Common stock	[6]	25,000	25,000
Additional paid-in capital		7,982,466	7,982,598
Accumulated other comprehensive loss		(79,520)	(18,002)
Accumulated deficit		(10,497,925)	(9,228,774)
TOTAL STOCKHOLDERS' DEFICIENCY		(2,569,978)	(1,239,177)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY		$ 159,485	$ 519,094
Commitments	[7]
Subsequent events	[8]

[1] See Note 5

[2] See Note 7

[3] See Note 8

[4] See Note 6

[5] $0.001 par value; 10,000,000 shares authorized at March 31, 2016 (December 31, 2015: 1,000,000), 1 share issued and outstanding as at March 31, 2016 and December 31, 2015, respectively. See Note 9

[6] $0.001 par value; 125,000,000 authorized as at March 31, 2016 (December 31, 2015: 100,000,000), 15,876,947 outstanding common shares as at March 31, 2016 and December 31, 2015 and 9,123,031 outstanding exchangeable shares as at March 31, 2016 and December 31, 2015. See Note 9

[7] See Note 11

[8] See Note 12